Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian
‘Disorder, fright and confusion’ : looking back at the devastating Wall Street crash of 1929
19/10/2025
David Harewood returns to Othello : ‘I don’t just want to open the door but kick it down for the people behind me’
19/10/2025
Historic town founded by Black Colombians fleeing slavery eyes second ‘independence’
19/10/2025
‘I felt my soul leave my body’ : 13 readers on the worst meal they ever cooked – from ‘ethanol risotto’ to gravy cake
19/10/2025
Developers encroach on 2,000-year-old Devon wetland citing ‘blockages’ to Labour’s housing plans
19/10/2025
‘I don’t really have sex to music, it’s a bit Tom Cruise’ : Miles Kane’s honest playlist
19/10/2025